Snow leopard in a high-altitude landscape
Private Systematic Investment Strategy
Love the Upside.
Pursue the Extraordinary.
Respect the Risk.
A market-regime-aware quantitative strategy built to stand alongside the world’s leading systematic funds—pursuing exceptional compounding through adaptive exposure and empirically evaluated rules.
SYSTEMATIC • ADAPTIVE
01 · LIVE FORWARD EVIDENCE

LIVE BROKERAGE PERFORMANCE

01 May 2026 — 28 Aug 2026 · Brokerage-derived ELOVEEE track record
METRICELOVEEENASDAQ-100
(QQQ)
S&P 500
(SPY)
Total Return+32.75%+6.39%+7.03%
Max Drawdown−10.01%−10.28%−5.50%
Sharpe2.790.791.05
Sortino5.871.181.54
Beta vs QQQ0.711.000.58
Live performance is presented separately from model validation.
*Live brokerage track record. Short observation period; not annualized.
02 · HISTORICAL MODEL VALIDATION

FEB 2012 — AUG 2026

Historical backtest · benchmark comparison
METRICELOVEEENASDAQ-100
(QQQ)
S&P 500
(SPY)
CAGR40.47%19.48%14.84%
Max Drawdown−13.66%−32.58%−23.93%
Sharpe1.470.890.79
Calmar2.960.600.62
Median 5Y CAGR40.91%17.92%13.86%
Worst 5Y CAGR20.02%12.09%6.65%
5Y Outperformance*100%——
40.5% CAGR. 40.9% median 5-year CAGR. Lower drawdown than both benchmarks. Nearly 5× QQQ’s Calmar. No historical 5-year window underperformed either benchmark.
*Historical backtest. Max Drawdown and Calmar use month-end observations; daily ELOVEEE Max Drawdown was −21.66%. Past performance is not predictive.
03 · ROBUSTNESS

NOT JUST PERFORMANCE

A strategy should survive more than one favorable specification.
150+NEARBY PARAMETER
VARIANTS
10K5-YEAR BLOCK-BOOTSTRAP
PATHS
10×TRANSACTION-COST
STRESS
1-MONTHEXECUTION-DELAY
STRESS
4DISTINCT HISTORICAL
SUBPERIODS
Performance remained resilient across nearby parameter variations, with drawdowns generally favorable relative to QQQ under multi-parameter stress—and always below QQQ in single-parameter tests.
04 · THE STRATEGY

ADAPTIVE EXPOSURE

A proprietary, market-regime-aware framework.
ELOVEEE adapts exposure gradually as market conditions and regimes evolve—seeking greater participation when conditions strengthen and progressively reducing risk as they deteriorate.
Proprietary signals, thresholds and implementation are not disclosed.
PROFESSIONAL INQUIRIES

ALLOCATION & RESEARCH INQUIRIES

For professional conversations regarding ELOVEEE, its research framework and verified live track record.

contact@eloveee.com